Tarsus Pharmaceuticals Inc (TARS)
49.57
+3.07
(+6.60%)
USD |
NASDAQ |
Nov 14, 10:31
Tarsus Pharmaceuticals 1 Year Total Returns (Daily): 170.8% for Nov. 13, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
November 13, 2024 | 170.8% |
November 12, 2024 | 172.3% |
November 11, 2024 | 180.9% |
November 08, 2024 | 198.8% |
November 07, 2024 | 191.2% |
November 06, 2024 | 192.3% |
November 05, 2024 | 185.4% |
November 04, 2024 | 188.8% |
November 01, 2024 | 226.0% |
October 31, 2024 | 212.4% |
October 30, 2024 | 216.8% |
October 29, 2024 | 218.8% |
October 28, 2024 | 188.3% |
October 25, 2024 | 197.7% |
October 24, 2024 | 190.0% |
October 23, 2024 | 198.9% |
October 22, 2024 | 189.9% |
October 21, 2024 | 178.0% |
October 18, 2024 | 175.3% |
October 17, 2024 | 176.4% |
October 16, 2024 | 167.9% |
October 15, 2024 | 187.2% |
October 14, 2024 | 181.0% |
October 11, 2024 | 122.2% |
October 10, 2024 | 115.4% |
Date | Value |
---|---|
October 09, 2024 | 112.9% |
October 08, 2024 | 93.51% |
October 07, 2024 | 89.02% |
October 04, 2024 | 89.44% |
October 03, 2024 | 83.35% |
October 02, 2024 | 87.79% |
October 01, 2024 | 81.71% |
September 30, 2024 | 85.09% |
September 27, 2024 | 105.9% |
September 26, 2024 | 104.4% |
September 25, 2024 | 98.16% |
September 24, 2024 | 94.87% |
September 23, 2024 | 95.75% |
September 20, 2024 | 106.0% |
September 19, 2024 | 103.5% |
September 18, 2024 | 96.68% |
September 17, 2024 | 92.38% |
September 16, 2024 | 97.52% |
September 13, 2024 | 121.9% |
September 12, 2024 | 92.94% |
September 11, 2024 | 87.28% |
September 10, 2024 | 95.89% |
September 09, 2024 | 94.70% |
September 06, 2024 | 89.41% |
September 05, 2024 | 64.32% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-65.87%
Minimum
Jun 10 2022
226.0%
Maximum
Nov 01 2024
16.13%
Average
-1.83%
Median
1 Year Total Returns (Daily) Benchmarks
Amicus Therapeutics Inc | 1.07% |
CEL-SCI Corp | -74.28% |
AIM ImmunoTech Inc | -44.75% |
IGC Pharma Inc | 19.61% |
NovaBay Pharmaceuticals Inc | -93.43% |